Global Names Drive Generics Returns

On the first trading day of 2018, the U.S. Food & Drug Administration (FDA) announced new steps to streamline the generic drug approval process in the United States. While this is potentially significant, it's notable that non-U.S. market opportunities for many generic drug companies have...

Source: VanEck Blog
Recommended posts powered by Google